|
2
|
|
Oral small-molecule GLP-1 receptor agonist safiglipron in early type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
(nature.com)
|
Yu M
…
Xiao X
Nature Medicine
2026-09-29
|
#diabetes
#clinical trial
#glp-1 agonist
#pharmacotherapy
#glycemic control
|
|
1
|
|
Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.
(linkinghub.elsevier.com)
|
Bellido V
…
Taylor A
The Lancet
2026-09-29
|
#clinical trial
#diabetes
#obesity
#pharmacotherapy
|
|
2
|
|
Retatrutide, a Triple Hormone Receptor Agonist, for Treatment of Obesity.
(nejm.org)
|
Jastreboff AM
…
Wang Y
New England Journal of Medicine
2026-09-29
|
#obesity
#pharmacotherapy
#agonist
#metabolism
|